Medtronic
MDT
2,064 hedge funds and large institutions have $94.6B invested in Medtronic in 2024 Q3 according to their latest regulatory filings, with 181 funds opening new positions, 759 increasing their positions, 903 reducing their positions, and 117 closing their positions.
55% more first-time investments, than exits
New positions opened: 181 | Existing positions closed: 117
35% more funds holding in top 10
Funds holding in top 10: 23 → 31 (+8)
13% more capital invested
Capital invested by funds: $83.5B → $94.6B (+$11.1B)
11% more call options, than puts
Call options by funds: $816M | Put options by funds: $735M
2% more funds holding
Funds holding: 2,024 → 2,064 (+40)
0.66% less ownership
Funds ownership: 82.71% → 82.05% (-0.66%)
16% less repeat investments, than reductions
Existing positions increased: 759 | Existing positions reduced: 903
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS AM
Chicago,
Illinois
|
+$503M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$401M |
| 3 |
Millennium Management
New York
|
+$356M |
| 4 |
Invesco
Atlanta,
Georgia
|
+$196M |
| 5 |
Lazard Asset Management
New York
|
+$191M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Sanders Capital
West Palm Beach,
Florida
|
-$916M |
| 2 |
Morgan Stanley
New York
|
-$401M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$266M |
| 4 |
Franklin Resources
San Mateo,
California
|
-$258M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$239M |
MDT Hedge Fund Activity: Q3 2024 in Review
2,064 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in Medtronic (MDT) for Q3 2024, worth a combined $94.6B — up 13% from $83.5B a quarter earlier.
Buyers outnumbered sellers: 181 funds opened new MDT positions and 117 closed out — a net gain of 64 holders — while 759 added to existing stakes and 903 trimmed.
The largest buyer was UBS AM, adding an estimated $503M. The largest seller was Sanders Capital, cutting an estimated $916M.
- 2,064 institutional investors held Medtronic (MDT) as of Q3 2024, up from 2,024 in Q2 2024.
- Funds reported $94.6B of Medtronic stock for Q3 2024, up 13% quarter-over-quarter.
- 181 funds opened new Medtronic positions in Q3 2024 and 117 closed out, a net change of +64 holders.
- The largest Medtronic buyer in Q3 2024 was UBS AM, an estimated $503M added.
- The largest Medtronic seller in Q3 2024 was Sanders Capital, an estimated $916M sold.
Based on aggregated 13F filings for Q3 2024.